Translational Development Acquisition Corp. (TDACW) Financial Statements
Translational Development Acquisition Corp. (TDACW) files with the U.S. Securities and Exchange Commission under CIK 0001926599. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2025
- Net Income
- $6.36 million
- Total Assets
- $181.70 million
- Net Cash from Operations
- -$608.39 thousand
Fiscal year ended Dec 31, 2025. Latest periodic SEC filing: Aug 14, 2026. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for TDACW in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History